AU2003213370A1 - External preparations for enhancing cell activity - Google Patents

External preparations for enhancing cell activity

Info

Publication number
AU2003213370A1
AU2003213370A1 AU2003213370A AU2003213370A AU2003213370A1 AU 2003213370 A1 AU2003213370 A1 AU 2003213370A1 AU 2003213370 A AU2003213370 A AU 2003213370A AU 2003213370 A AU2003213370 A AU 2003213370A AU 2003213370 A1 AU2003213370 A1 AU 2003213370A1
Authority
AU
Australia
Prior art keywords
cell activity
external preparations
enhancing cell
enhancing
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003213370A
Inventor
Akira Yamada
Hajime Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAC Corp
Original Assignee
CAC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CAC Corp filed Critical CAC Corp
Publication of AU2003213370A1 publication Critical patent/AU2003213370A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU2003213370A 2002-04-16 2003-03-05 External preparations for enhancing cell activity Abandoned AU2003213370A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-113217 2002-04-16
JP2002113217A JP3885204B2 (en) 2002-04-16 2002-04-16 External agent for promoting cell activity
PCT/JP2003/002536 WO2003086421A1 (en) 2002-04-16 2003-03-05 External preparations for enhancing cell activity

Publications (1)

Publication Number Publication Date
AU2003213370A1 true AU2003213370A1 (en) 2003-10-27

Family

ID=29243346

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003213370A Abandoned AU2003213370A1 (en) 2002-04-16 2003-03-05 External preparations for enhancing cell activity

Country Status (6)

Country Link
JP (1) JP3885204B2 (en)
CN (1) CN1240392C (en)
AU (1) AU2003213370A1 (en)
HK (1) HK1060048A1 (en)
TW (1) TWI254639B (en)
WO (1) WO2003086421A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005053841A (en) * 2003-08-05 2005-03-03 Kyouto Biomedical Science:Kk Skin care preparation for external use
CN1285382C (en) * 2004-12-20 2006-11-22 凌沛学 Transmission system of drug for nasal cavity of containing trehalose and byaluronic acid, and preparation method
DE102007052380A1 (en) * 2007-10-31 2009-05-07 Bitop Ag Osmolyte-containing preparations for use in dry mucous membranes
JP5620168B2 (en) * 2010-06-30 2014-11-05 Ｄｓｐ五協フード＆ケミカル株式会社 Xyloglucan-cation complex and stabilized composition containing the same
CN103239571B (en) * 2013-05-26 2014-09-03 广州市云桥生物科技有限公司 Chinese medicine effective part composition for treating alopecia areata and preparation method thereof
JP6313118B2 (en) * 2014-05-16 2018-04-18 株式会社Cac IgE inhibitor
EP3355893A4 (en) * 2015-09-29 2019-06-12 Kimberly-Clark Worldwide, Inc. Synergistic composition for maintenance of healthy balance of microflora
FR3064473B1 (en) * 2017-04-03 2021-02-12 Basf Beauty Care Solutions France Sas PROTECTIVE INGREDIENT OF THE BALANCE OF SKIN AND / OR MUCOSAL MICROBIAL FLORA
BE1027425B1 (en) * 2019-07-01 2021-02-08 Aquilon Pharmaceuticals INHALABLE COMPOSITION INCLUDING CYCLODEXTRIN FOR USE IN THE TREATMENT OF NASAL INFLAMMATIONS
WO2023060613A1 (en) * 2021-10-16 2023-04-20 南通市巨久新材料科技有限公司 Peripheral blood mononuclear cell culture dish containing coriolus versicolor mushroom polysaccharide coating layer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03204804A (en) * 1989-12-28 1991-09-06 Mitsui Toatsu Chem Inc Skin cosmetic
JP2681527B2 (en) * 1990-02-15 1997-11-26 ジャパンファインケミカル株式会社 Topical for promoting cell activity
DE19710368A1 (en) * 1997-03-13 1998-09-17 Henkel Kgaa Use of water-soluble beta-glucans as active ingredients for the production of therapeutic agents for skin treatment
JP2002275046A (en) * 2001-03-23 2002-09-25 Kanebo Ltd Agent for enhancing barrier against penetration through epidermis, and skin care composition

Also Published As

Publication number Publication date
JP2005289815A (en) 2005-10-20
JP3885204B2 (en) 2007-02-21
CN1451389A (en) 2003-10-29
TW200407154A (en) 2004-05-16
HK1060048A1 (en) 2004-07-30
WO2003086421A1 (en) 2003-10-23
TWI254639B (en) 2006-05-11
CN1240392C (en) 2006-02-08

Similar Documents

Publication Publication Date Title
AU2003273000A1 (en) Stable solid preparations
AU2003276101A1 (en) Electrochemical system
AU2003265826A1 (en) Electrolyte
AU2003259152A1 (en) Cell therapy for regeneration
AU2003247514A1 (en) Meningeal-derived stem cells
AU2002317418A1 (en) Cell enumeration
AU2003229066A1 (en) Interface architecture
AU2003290432A1 (en) T cell activating gene
AU2003290685A1 (en) Active fasteners
AU2003243399A1 (en) Electrochemical conversion system
AU2003242258A1 (en) Battery
AU2003250100A1 (en) Electrochemical cell
AU2003280813A1 (en) Active antenna
AU2003213370A1 (en) External preparations for enhancing cell activity
AU2003289942A1 (en) Electrochemical cell
AU2003211963A1 (en) Percutaneous preparations
AU2003279967A1 (en) Photoelectric cell
AU2003216267A1 (en) Plant preparations
AU2003261366A1 (en) Methods for regulating brca1-brca2-containing complex activity
AU2003201853A1 (en) Skin preparations for external use
AU2003235285A1 (en) Battery
AU2003264443A1 (en) Preparation for external use
AU2003217037A1 (en) Stem cell therapy
AU2002329162A1 (en) Cell culture system
AUPR673001A0 (en) Pregnancy-related enzyme activity

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase